✦ LIBER ✦

Safety and Efficacy of 8-mg Once-daily vs 4-mg Twice-daily Silodosin in Patients With Lower Urinary Tract Symptoms Suggestive of Benign Prostatic Hyperplasia (SILVER Study): A 12-Week, Double-blind, Randomized, Parallel, Multicenter Study

✍ Scribed by Choo, Myung-Soo; Song, Miho; Kim, Jang Hwan; Lee, Kyu-Sung; Kim, Joon Chul; Kim, Sae Woong; Yang, Sang-Kuk; Lee, Jeong Gu; Lee, Jeong Zoo; Kim, Dae Kyung; Park, Won Hee; Kim, Kyung Do; Na, Yong Gil; Kwon, Dong Deuk; Paick, Jae-Seung

Book ID: 122296412
Publisher: Elsevier Science
Year: 2014
Tongue: English
Weight: 418 KB
Volume: 83
Category: Article
ISSN: 0090-4295
DOI: 10.1016/j.urology.2013.11.013

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Efficacy and Safety of Tadalafil 5 mg On

Efficacy and Safety of Tadalafil 5 mg Once Daily for Lower Urinary Tract Symptoms Suggestive of Benign Prostatic Hyperplasia: Subgroup Analyses of Pooled Data From 4 Multinational, Randomized, Placebo-controlled Clinical Studies

✍ Porst, Hartmut; Oelke, Matthias; Goldfischer, Evan R.; Cox, David; Watts, Steven 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 265 KB

Safety and efficacy of alfuzosin 10 mg o

Safety and efficacy of alfuzosin 10 mg once-daily in the treatment of lower urinary tract symptoms and clinical benign prostatic hyperplasia: a pooled analysis of three double-blind, placebo-controlled studies

✍ M.G. Wyllie 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 97 KB

Tadalafil 2.5 or 5 mg Administered Once

Tadalafil 2.5 or 5 mg Administered Once Daily for 12 Weeks in Men with Both Erectile Dysfunction and Signs and Symptoms of Benign Prostatic Hyperplasia: Results of a Randomized, Placebo-Controlled, Double-Blind Study

✍ Russell Blair Egerdie; Stephen Auerbach; Claus G. Roehrborn; Pierre Costa; Marti 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 244 KB

Tadalafil 2.5 or 5mg administered once d

Tadalafil 2.5 or 5mg administered once daily for 12 weeks in men with both erectile dysfunction and signs and symptoms of benign prostatic hyperplasia: Results of a randomized, placebo-controlled, double-blind study

✍ Egerdie, Russell Blair (author);Auerbach, Stephen (author);Roehrborn, Claus G. ( 📂 Article 📅 2012 🏛 Blackwell Publishing Ltd 🌐 English ⚖ 244 KB

Re: Hartmut Porst, Edward D. Kim, Adolfo

Re: Hartmut Porst, Edward D. Kim, Adolfo R. Casabé, et al., for the LVHJ study team. Efficacy and Safety of Tadalafil Once Daily in the Treatment of Men With Lower Urinary Tract Symptoms Suggestive of Benign Prostatic Hyperplasia: Results of an International Randomized, Double-Blind, Placebo-Controlled Trial. Eur Urol 2011;60:1105–13

✍ Ege Can Serefoglu; Gregory C. Mitchell; Wayne J.G. Hellstrom 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 79 KB

Reply to Ege Can Serefoglu, Gregory C. M

Reply to Ege Can Serefoglu, Gregory C. Mitchell, and Wayne J.G. Hellstrom's Letter to the Editor re: Hartmut Porst, Edward D. Kim, Adolfo R. Casabé, et al., for the LVHJ study team. Efficacy and Safety of Tadalafil Once Daily in the Treatment of Men With Lower Urinary Tract Symptoms Suggestive of Benign Prostatic Hyperplasia: Results of an International Randomized, Double-Blind, Placebo-Controlled Trial. Eur Urol 2011;60:1105–13

✍ Hartmut Porst; Edward D. Kim; Adolfo R. Casabé; Vincenzo Mirone; Roberta J. Secr 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 83 KB